The Readout Loud
A podcast by STAT - Thursdays
Categories:
336 Episodes
-
Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges
Published: 3/28/2019 -
Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores
Published: 3/21/2019 -
Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen
Published: 3/14/2019 -
Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation
Published: 3/7/2019 -
Episode 51: CEOs at the Senate, merger mania, and sleuthing startups
Published: 2/28/2019 -
Episode 50: A big scoop on opioid marketing
Published: 2/22/2019 -
Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill
Published: 2/21/2019 -
Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH
Published: 2/14/2019 -
Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?
Published: 2/7/2019 -
Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns
Published: 1/31/2019 -
Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics
Published: 1/24/2019 -
Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics
Published: 1/17/2019 -
Episode 43: A people's history of J.P. Morgan
Published: 1/10/2019 -
Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring
Published: 1/3/2019 -
Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta
Published: 12/20/2018 -
Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests
Published: 12/13/2018 -
Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history
Published: 12/6/2018 -
Episode 38: Your guide to the #CRISPRbabies controversy
Published: 11/29/2018 -
Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts
Published: 11/15/2018 -
Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug
Published: 11/8/2018
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.